STOCK TITAN
  1. Home
  2. News
  3. RVMD

Revolution Medicines Inc - RVMD STOCK NEWS

IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Provide R&D Update, Including Expansion of Development-Stage RAS(ON) Inhibitor Pipeline, During Presentation at 40th Annual J.P. Morgan Healthcare Conference
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in 4th Annual Evercore ISI HealthCONx Conference
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress
earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in Stifel 2021 Virtual Healthcare Conference
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Report Financial Results for Third Quarter 2021 After Market Close on November 10, 2021
conferences earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Present New Preclinical Data from RAS(ON) Inhibitor Programs at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
conferences clinical trial
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Present at H.C. Wainwright 23rd Annual Global Investment Conference
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress
earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Report Financial Results for Second Quarter 2021 After Market Close on August 11, 2021
conferences earnings
Stock RVMD logo
Revolution Medicines Inc

Nasdaq:RVMD

RVMD Rankings

#1663 Ranked by Market Cap
#2552 Ranked by Stock Gains
N/A Ranked by Dividends

RVMD Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Redwood City

About RVMD

revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.